Project Grant R61MH138733
- Federal Grant Award Summary Boston University Medical Campus received a $191,972 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded on September 8, 2025, with a completion date of August 31, 2030. The award supports a pilot randomized controlled trial examining an adapted form of Cognitive Processing Therapy (CPT) for posttraumatic stress disorder (PTSD) in populations experiencing health disparities. The...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $1.13M project grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded May 7, 2025, with completion targeted for February 28, 2029. The research initiative investigates the structural and functional architecture of cortico-cerebellar systems in posttraumatic stress disorder (PTSD) and trauma exposure. The project addresses a...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded McLean Hospital a $777,016 Project Grant under the Mental Health Research Grants program (CFDA 93.242) effective July 1, 2025, through April 30, 2030. This research project investigates the synaptic mechanisms of continuous theta burst stimulation (cTBS), an FDA-cleared repetitive transcranial magnetic stimulation (rTMS) protocol used to treat treatment-resistant depression. The primary deliverables include...
- Federal Grant Award Summary Boston Medical Center Corporation received a $939,784 Project Grant from the National Institute of Mental Health (Mental Health Research Grants, CFDA 93.242) awarded August 1, 2025, through July 31, 2030. The grant supports development and implementation of an adaptive (stepped) intervention designed to improve access, engagement, and effectiveness of posttraumatic stress disorder (PTSD) treatment in routine care settings. The intervention sequences a digital...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $1,402,271 Project Grant to The Washington University's Office of Sponsored Research Services on May 1, 2025, with a completion date of February 28, 2029, under the Mental Health Research Grants program (CFDA 93.242). This research project, titled "Predicting Attenuated Psychotic Symptoms Amongst Youth Endorsing Persistent Distressing Psychotic-Like Experiences," delivers comprehensive scientific...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $743,045 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 20, 2025, with completion scheduled for August 31, 2030. This award supports a five-year research project investigating the long-term consequences of extinction enhancement as a therapeutic intervention for post-traumatic stress disorder (PTSD). The...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a $728,751 Project Grant to the University of Pittsburgh under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2031. This research project investigates the neural mechanisms underlying antidepressant placebo effects in patients with major depressive disorder (MDD). The study employs theta burst stimulation (TBS) to examine the causal roles of the salience...
- Federal Grant Award Summary Ampa Inc. received a $1.2M Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded September 15, 2025, with completion targeted for August 31, 2027. The award funds development and validation of NextGenTM, a next-generation transcranial magnetic stimulation (TMS) system designed to democratize access to advanced depression treatment. The system incorporates three key innovations:...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Medical University of South Carolina a $208,794 Project Grant on March 5, 2026, under the Mental Health Research Grants program (CFDA 93.242) to support a K23 research and training initiative led by Dr. Emily Tilstra-Ferrell. The grant funds the development and testing of an adapted written exposure therapy (WET) intervention for adolescents with posttraumatic stress disorder (PTSD). Through this five-year...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded The Washington University a Project Grant of $284,333.00 under the Mental Health Research Grants program (CFDA 93.242), effective August 4, 2025, through June 30, 2029. The award supports research on mechanism-based dose titration for modifying brain electrophysiology during antidepressant therapy, with a specific focus on treatment-resistant depression (TRD). The project develops personalized medicine...
Emory University has received a $1,229,954 Project Grant from the National Institute of Mental Health under the Mental Health Research Grants program (CFDA 93.242) for the period April 1, 2026 through March 31, 2028. The award funds the PREVENT Study: Promoting Resilience via Early Neurostimulation After Trauma, a clinical research initiative designed to prevent chronic post-traumatic stress disorder (PTSD) and depression in trauma survivors by targeting early brain-based risk mechanisms. The research leverages transcranial magnetic stimulation (TMS), a non-invasive neuromodulation technique, to dampen amygdala hyperreactivity—a well-established neurobiological predictor of chronic PTSD symptoms—in emergency department patients within one week of trauma exposure. The R61 phase of the project will deliver a staged single-blind TMS intervention with escalating active treatment doses following a lead-in sham condition, with key deliverables including: (1) demonstration of target engagement showing active TMS reduces amygdala threat reactivity compared to sham treatment, and (2) determination of optimal dose-response relationships between one and four TMS sessions. By intervening early after trauma exposure, the research aims to prevent the cascade of debilitating symptoms including hyper-arousal, intrusive memories, and negative affect that characterize chronic PTSD.PREVENT Study Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.2m | 3/16/26 |